We at Guidant recognize that there is an increased appetite for information from our industry among physicians and patients. We have also asked an independent panel of outside experts to provide recommendations. |
We do not expect this development to interfere with the progress of the pending merger between Guidant and Boston Scientific. |
We do not expect this development to interfere with the progress of the pending merger. |